title: Reply: To PMID 24519039.
authors.affiliation: Department of Infectious Diseases/Virology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
authors.forename: Martin
authors.initials: M
authors.lastname: Lagging
authors.forename: Karolina
authors.initials: K
authors.lastname: Rembeck
authors.forename: Jesper
authors.initials: J
authors.lastname: Waldenström
authors.forename: Staffan
authors.initials: S
authors.lastname: Nilsson
authors.forename: Kristina
authors.initials: K
authors.lastname: Nyström
authors.forename: Anna
authors.initials: A
authors.lastname: Martner
authors.forename: Magnus
authors.initials: M
authors.lastname: Lindh
authors.forename: Gunnar
authors.initials: G
authors.lastname: Norkrans
authors.forename: Johan
authors.initials: J
authors.lastname: Westin
authors.forename: Court
authors.initials: C
authors.lastname: Pedersen
authors.forename: Martti
authors.initials: M
authors.lastname: Färkkilä
authors.forename: Nina
authors.initials: N
authors.lastname: Langeland
authors.forename: Mads Rauning
authors.initials: MR
authors.lastname: Buhl
authors.forename: Kristine
authors.initials: K
authors.lastname: Mørch
authors.forename: Peer B
authors.initials: PB
authors.lastname: Christensen
authors.forename: Kristoffer
authors.initials: K
authors.lastname: Hellstrand
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D014644:Genetic Variation; D006526:Hepatitis C / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D011755:Pyrophosphatases / Q000235:genetics*; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin; D011755:Pyrophosphatases